| | | | | | | | | | |
| | | | Year ended December 31, |
| | | | 2024 | | 2023 | | 2022 |
Name of the subsidiary | | Country | | % voting right
Galapagos NV
(directly or
indirectly
through
subsidiaries) | | Change in %
voting right
previous
period (2024
vs 2023) | | % voting right
Galapagos NV
(directly or
indirectly
through
subsidiaries) | | % voting right
Galapagos NV
(directly or
indirectly
through
subsidiaries) |
| | | | | | | | | | |
CONTINUING OPERATIONS | | | | | | | | | | |
GLPG US Inc. (formerly AboundBio Inc.) | | United States | | 100% | | | | 100% | | 100% |
CellPoint B.V. (till 11/30/2023) | | The Netherlands | | 100% | | | | 100% | | 100% |
Galapagos B.V. (merged with CellPoint B.V.) | | The Netherlands | | 100% | | | | 100% | | 100% |
Galapagos GmbH | | Switzerland | | 100% | | | | 100% | | 100% |
GLPG US Holding Inc. (formerly Galapagos, Inc.) | | United States | | 100% | | | | 100% | | 100% |
Galapagos NV | | Belgium | | Parent company | | | | Parent company | | Parent company |
Galapagos Real Estate Belgium BV (former Galapagos Real Estate 1 BV) | | Belgium | | 100% | | | | 100% | | 100% |
Galapagos Real Estate Netherlands B.V. | | The Netherlands | | 100% | | | | 100% | | 100% |
Galapagos U.K. Limited | | United Kingdom | | 100% | | 100% | | 0% | | 0% |
Galapagos SASU | | France | | 100% | | | | 100% | | 100% |
Xenometrix, Inc. in liquidation | | United States | | 100% | | | | 100% | | 100% |
Galapagos Holding PTE. LTD. | | Singapore | | 100% | | 100% | | 0% | | 0% |
| | | | | | | | | | |
DISCONTINUED OPERATIONS | | | | | | | | | | |
Galapagos Biopharma Belgium BV | | Belgium | | 0% | | -100% | | 100% | | 100% |
Galapagos Biopharma Netherlands B.V. | | The Netherlands | | 0% | | -100% | | 100% | | 100% |
Galapagos Biopharma Spain S.L.U. | | Spain | | 0% | | -100% | | 100% | | 100% |
Galapagos Biopharma Italy S.r.l. | | Italy | | 0% | | -100% | | 100% | | 100% |
Galapagos Biopharma Germany GmbH | | Germany | | 0% | | -100% | | 100% | | 100% |
Galapagos Biopharma Sweden AB | | Sweden | | 0% | | -100% | | 100% | | 100% |
Galapagos Biopharma Norway AS | | Norway | | 0% | | -100% | | 100% | | 100% |
Galapagos Biopharma Finland Oy | | Finland | | 0% | | -100% | | 100% | | 100% |
Galapagos Biopharma Denmark ApS | | Denmark | | 0% | | -100% | | 100% | | 100% |
Galapagos Biopharma Austria GmbH | | Austria | | 0% | | -100% | | 100% | | 100% |
Galapagos Biopharma Ireland Ltd | | Ireland | | 0% | | -100% | | 100% | | 100% |
Galapagos Biotech Ltd (formerly Inpharmatica Ltd.) | | United Kingdom | | 0% | | -100% | | 100% | | 100% |